Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 25, 2019 Filed Mar 26, 2019 21:26 UTC |
Silva FranciscoVP of Research and Development
|
GrantStock Option · Derivative | 60,000 | Not disclosed Strike: $0.75 | Not disclosed |
DisclosureSEC source: 0001567619-19-007667 · doc1.xml · derivative · entry 28 Silva Francisco · CIK 0001527241 · VP of Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2026-06-10 F12 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F9 · derivative.exercise_date: The option is exercisable to the extent of 20,000 shares on each of June 10, 2017, June 10, 2018 and June 10, 2019. Read SEC document |
| March 25, 2019 Filed Mar 26, 2019 21:26 UTC |
Silva FranciscoVP of Research and Development
|
Disposition to issuerStock Option · Derivative | 60,000 | Not disclosed Strike: $3.73 | Not disclosed |
DisclosureSEC source: 0001567619-19-007667 · doc1.xml · derivative · entry 27 Silva Francisco · CIK 0001527241 · VP of Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 60,000 shares Expires 2026-06-10 F12 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F9 · derivative.exercise_date: The option is exercisable to the extent of 20,000 shares on each of June 10, 2017, June 10, 2018 and June 10, 2019. Read SEC document |
| March 25, 2019 Filed Mar 26, 2019 21:26 UTC |
Silva FranciscoVP of Research and Development
|
GrantStock Option · Derivative | 25,000 | Not disclosed Strike: $0.75 | Not disclosed |
DisclosureSEC source: 0001567619-19-007667 · doc1.xml · derivative · entry 26 Silva Francisco · CIK 0001527241 · VP of Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2025-09-04 F12 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F8 · derivative.exercise_date: The option is exercisable to the extent of 8,334 shares on September 4, 2016 and 8,333 shares on each of September 4, 2017 and September 4, 2018. Read SEC document |
| March 25, 2019 Filed Mar 26, 2019 21:26 UTC |
Silva FranciscoVP of Research and Development
|
Disposition to issuerStock Option · Derivative | 25,000 | Not disclosed Strike: $4.70 | Not disclosed |
DisclosureSEC source: 0001567619-19-007667 · doc1.xml · derivative · entry 25 Silva Francisco · CIK 0001527241 · VP of Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,000 shares Expires 2025-09-04 F12 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F8 · derivative.exercise_date: The option is exercisable to the extent of 8,334 shares on September 4, 2016 and 8,333 shares on each of September 4, 2017 and September 4, 2018. Read SEC document |
| March 25, 2019 Filed Mar 26, 2019 21:26 UTC |
Silva FranciscoVP of Research and Development
|
GrantStock Option · Derivative | 37,500 | Not disclosed Strike: $0.75 | Not disclosed |
DisclosureSEC source: 0001567619-19-007667 · doc1.xml · derivative · entry 24 Silva Francisco · CIK 0001527241 · VP of Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,500 Underlying: Common Stock · 37,500 shares Expires 2024-10-23 F12 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F7 · derivative.exercise_date: The option is exercisable to the extent of 12,500 shares on each of October 23, 2015, October 23, 2016 and October 23, 2017. Read SEC document |
| March 25, 2019 Filed Mar 26, 2019 21:26 UTC |
Silva FranciscoVP of Research and Development
|
Disposition to issuerStock Option · Derivative | 37,500 | Not disclosed Strike: $4.70 | Not disclosed |
DisclosureSEC source: 0001567619-19-007667 · doc1.xml · derivative · entry 23 Silva Francisco · CIK 0001527241 · VP of Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 37,500 shares Expires 2024-10-23 F12 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F7 · derivative.exercise_date: The option is exercisable to the extent of 12,500 shares on each of October 23, 2015, October 23, 2016 and October 23, 2017. Read SEC document |
| March 25, 2019 Filed Mar 26, 2019 21:26 UTC |
Silva FranciscoVP of Research and Development
|
GrantStock Option · Derivative | 2,000 | Not disclosed Strike: $0.75 | Not disclosed |
DisclosureSEC source: 0001567619-19-007667 · doc1.xml · derivative · entry 22 Silva Francisco · CIK 0001527241 · VP of Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Underlying: Common Stock · 2,000 shares Expires 2022-05-02 F12 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. Read SEC document |
| March 25, 2019 Filed Mar 26, 2019 21:26 UTC |
Silva FranciscoVP of Research and Development
|
Disposition to issuerStock Option · Derivative | 2,000 | Not disclosed Strike: $4.70 | Not disclosed |
DisclosureSEC source: 0001567619-19-007667 · doc1.xml · derivative · entry 21 Silva Francisco · CIK 0001527241 · VP of Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,000 shares Expires 2022-05-02 F12 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. Read SEC document |
| March 25, 2019 Filed Mar 26, 2019 21:26 UTC |
Silva FranciscoVP of Research and Development
|
GrantStock Option · Derivative | 2,000 | Not disclosed Strike: $0.75 | Not disclosed |
DisclosureSEC source: 0001567619-19-007667 · doc1.xml · derivative · entry 20 Silva Francisco · CIK 0001527241 · VP of Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Underlying: Common Stock · 2,000 shares Expires 2024-03-11 F12 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. Read SEC document |
| March 25, 2019 Filed Mar 26, 2019 21:26 UTC |
Silva FranciscoVP of Research and Development
|
Disposition to issuerStock Option · Derivative | 2,000 | Not disclosed Strike: $4.70 | Not disclosed |
DisclosureSEC source: 0001567619-19-007667 · doc1.xml · derivative · entry 19 Silva Francisco · CIK 0001527241 · VP of Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,000 shares Expires 2024-03-11 F12 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. Read SEC document |
| March 25, 2019 Filed Mar 26, 2019 21:26 UTC |
Silva FranciscoVP of Research and Development
|
GrantStock Option · Derivative | 12,500 | Not disclosed Strike: $0.75 | Not disclosed |
DisclosureSEC source: 0001567619-19-007667 · doc1.xml · derivative · entry 18 Silva Francisco · CIK 0001527241 · VP of Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,500 Underlying: Common Stock · 12,500 shares Expires 2024-02-18 F12 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F6 · derivative.exercise_date: The option is exercisable to the extent of 4,167 shares on each of February 18, 2014 and February 18, 2015, and 4,166 shares on February 18, 2016. Read SEC document |
| March 25, 2019 Filed Mar 26, 2019 21:26 UTC |
Silva FranciscoVP of Research and Development
|
Disposition to issuerStock Option · Derivative | 12,500 | Not disclosed Strike: $4.70 | Not disclosed |
DisclosureSEC source: 0001567619-19-007667 · doc1.xml · derivative · entry 17 Silva Francisco · CIK 0001527241 · VP of Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,500 shares Expires 2024-02-18 F12 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F6 · derivative.exercise_date: The option is exercisable to the extent of 4,167 shares on each of February 18, 2014 and February 18, 2015, and 4,166 shares on February 18, 2016. Read SEC document |
| March 25, 2019 Filed Mar 26, 2019 21:26 UTC |
Silva FranciscoVP of Research and Development
|
GrantStock Option · Derivative | 5,000 | Not disclosed Strike: $0.75 | Not disclosed |
DisclosureSEC source: 0001567619-19-007667 · doc1.xml · derivative · entry 16 Silva Francisco · CIK 0001527241 · VP of Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2023-10-04 F12 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F5 · derivative.exercise_date: The option is exercisable to the extent of 2,500 shares on each of October 4, 2013 and October 4, 2014. Read SEC document |
| March 25, 2019 Filed Mar 26, 2019 21:26 UTC |
Silva FranciscoVP of Research and Development
|
Disposition to issuerStock Option · Derivative | 5,000 | Not disclosed Strike: $4.70 | Not disclosed |
DisclosureSEC source: 0001567619-19-007667 · doc1.xml · derivative · entry 15 Silva Francisco · CIK 0001527241 · VP of Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2023-10-04 F12 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F5 · derivative.exercise_date: The option is exercisable to the extent of 2,500 shares on each of October 4, 2013 and October 4, 2014. Read SEC document |
| March 25, 2019 Filed Mar 26, 2019 21:26 UTC |
Silva FranciscoVP of Research and Development
|
GrantStock Option · Derivative | 4,000 | Not disclosed Strike: $0.75 | Not disclosed |
DisclosureSEC source: 0001567619-19-007667 · doc1.xml · derivative · entry 14 Silva Francisco · CIK 0001527241 · VP of Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,000 Underlying: Common Stock · 4,000 shares Expires 2022-12-07 F12 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F4 · derivative.exercise_date: The option is exercisable to the extent of 2,000 shares on each of December 7, 2012 and December 7, 2013. Read SEC document |
| March 25, 2019 Filed Mar 26, 2019 21:26 UTC |
Silva FranciscoVP of Research and Development
|
Disposition to issuerStock Option · Derivative | 4,000 | Not disclosed Strike: $4.70 | Not disclosed |
DisclosureSEC source: 0001567619-19-007667 · doc1.xml · derivative · entry 13 Silva Francisco · CIK 0001527241 · VP of Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,000 shares Expires 2022-12-07 F12 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F4 · derivative.exercise_date: The option is exercisable to the extent of 2,000 shares on each of December 7, 2012 and December 7, 2013. Read SEC document |
| March 25, 2019 Filed Mar 26, 2019 21:26 UTC |
Silva FranciscoVP of Research and Development
|
GrantStock Option · Derivative | 5,500 | Not disclosed Strike: $0.75 | Not disclosed |
DisclosureSEC source: 0001567619-19-007667 · doc1.xml · derivative · entry 12 Silva Francisco · CIK 0001527241 · VP of Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,500 Underlying: Common Stock · 5,500 shares Expires 2022-05-02 F12 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F3 · derivative.exercise_date: The option is exercisable to the extent of 500 shares on each of May 3, 2013, May 3, 2014 and May 3, 2015, became exercisable to the extent of 1,000 shares based on the satisfaction of certain conditions and is exercisable to the extent of 3,000 shares subject to the satisfaction of certain conditions. Read SEC document |
| March 25, 2019 Filed Mar 26, 2019 21:26 UTC |
Silva FranciscoVP of Research and Development
|
Disposition to issuerStock Option · Derivative | 5,500 | Not disclosed Strike: $4.70 | Not disclosed |
DisclosureSEC source: 0001567619-19-007667 · doc1.xml · derivative · entry 11 Silva Francisco · CIK 0001527241 · VP of Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,500 shares Expires 2022-05-02 F12 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F3 · derivative.exercise_date: The option is exercisable to the extent of 500 shares on each of May 3, 2013, May 3, 2014 and May 3, 2015, became exercisable to the extent of 1,000 shares based on the satisfaction of certain conditions and is exercisable to the extent of 3,000 shares subject to the satisfaction of certain conditions. Read SEC document |
| March 25, 2019 Filed Mar 26, 2019 21:26 UTC |
Silva FranciscoVP of Research and Development
|
GrantStock Option · Derivative | 2,000 | Not disclosed Strike: $0.75 | Not disclosed |
DisclosureSEC source: 0001567619-19-007667 · doc1.xml · derivative · entry 10 Silva Francisco · CIK 0001527241 · VP of Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Underlying: Common Stock · 2,000 shares Expires 2022-02-09 F12 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F2 · derivative.exercise_date: The option is exercisable to the extent of 1,000 shares on each of February 10, 2012 and February 10, 2013. Read SEC document |
| March 25, 2019 Filed Mar 26, 2019 21:26 UTC |
Silva FranciscoVP of Research and Development
|
Disposition to issuerStock Option · Derivative | 2,000 | Not disclosed Strike: $4.70 | Not disclosed |
DisclosureSEC source: 0001567619-19-007667 · doc1.xml · derivative · entry 9 Silva Francisco · CIK 0001527241 · VP of Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,000 shares Expires 2022-02-09 F12 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F2 · derivative.exercise_date: The option is exercisable to the extent of 1,000 shares on each of February 10, 2012 and February 10, 2013. Read SEC document |
| March 25, 2019 Filed Mar 26, 2019 21:26 UTC |
Silva FranciscoVP of Research and Development
|
GrantStock Option · Derivative | 1,000 | Not disclosed Strike: $0.75 | Not disclosed |
DisclosureSEC source: 0001567619-19-007667 · doc1.xml · derivative · entry 8 Silva Francisco · CIK 0001527241 · VP of Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000 Underlying: Common Stock · 1,000 shares Expires 2021-11-15 F12 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. Read SEC document |
| March 25, 2019 Filed Mar 26, 2019 21:26 UTC |
Silva FranciscoVP of Research and Development
|
Disposition to issuerStock Option · Derivative | 1,000 | Not disclosed Strike: $4.70 | Not disclosed |
DisclosureSEC source: 0001567619-19-007667 · doc1.xml · derivative · entry 7 Silva Francisco · CIK 0001527241 · VP of Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,000 shares Expires 2021-11-15 F12 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. Read SEC document |
| March 25, 2019 Filed Mar 26, 2019 21:26 UTC |
Silva FranciscoVP of Research and Development
|
GrantStock Option · Derivative | 150 | Not disclosed Strike: $0.75 | Not disclosed |
DisclosureSEC source: 0001567619-19-007667 · doc1.xml · derivative · entry 6 Silva Francisco · CIK 0001527241 · VP of Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150 Underlying: Common Stock · 150 shares Expires 2021-06-23 F12 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. Read SEC document |
| March 25, 2019 Filed Mar 26, 2019 21:26 UTC |
Silva FranciscoVP of Research and Development
|
Disposition to issuerStock Option · Derivative | 150 | Not disclosed Strike: $4.70 | Not disclosed |
DisclosureSEC source: 0001567619-19-007667 · doc1.xml · derivative · entry 5 Silva Francisco · CIK 0001527241 · VP of Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 150 shares Expires 2021-06-23 F12 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. Read SEC document |
| March 25, 2019 Filed Mar 26, 2019 21:26 UTC |
Silva FranciscoVP of Research and Development
|
GrantStock Option · Derivative | 4,000 | Not disclosed Strike: $0.75 | Not disclosed |
DisclosureSEC source: 0001567619-19-007667 · doc1.xml · derivative · entry 4 Silva Francisco · CIK 0001527241 · VP of Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,000 Underlying: Common Stock · 4,000 shares Expires 2021-04-04 F12 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F1 · derivative.exercise_date: The option is exercisable to the extent of 2,000 shares on each of April 5, 2011 and April 5, 2012. Read SEC document |
| March 25, 2019 Filed Mar 26, 2019 21:26 UTC |
Silva FranciscoVP of Research and Development
|
Disposition to issuerStock Option · Derivative | 4,000 | Not disclosed Strike: $4.70 | Not disclosed |
DisclosureSEC source: 0001567619-19-007667 · doc1.xml · derivative · entry 3 Silva Francisco · CIK 0001527241 · VP of Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,000 shares Expires 2021-04-04 F12 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F1 · derivative.exercise_date: The option is exercisable to the extent of 2,000 shares on each of April 5, 2011 and April 5, 2012. Read SEC document |
| March 25, 2019 Filed Mar 26, 2019 21:21 UTC |
Weinreb MarkDirector · CEO and Chairman of the Board
|
GrantStock Option · Derivative | 275,000 | Not disclosed Strike: $0.75 | Not disclosed |
DisclosureSEC source: 0001567619-19-007663 · doc1.xml · derivative · entry 21 Weinreb Mark · CIK 0001527212 · Director · CEO and Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 275,000 Underlying: Common Stock · 275,000 shares Expires 2028-10-29 F10 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F9 · derivative.exercise_date: The option is exercisable to the extent of 91,667 shares on each of October 29, 2018 and October 29, 2019, and 91,666 shares on October 29, 2020. Read SEC document |
| March 25, 2019 Filed Mar 26, 2019 21:21 UTC |
Weinreb MarkDirector · CEO and Chairman of the Board
|
Disposition to issuerStock Option · Derivative | 275,000 | Not disclosed Strike: $1.23 | Not disclosed |
DisclosureSEC source: 0001567619-19-007663 · doc1.xml · derivative · entry 20 Weinreb Mark · CIK 0001527212 · Director · CEO and Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 275,000 shares Expires 2028-10-29 F10 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F9 · derivative.exercise_date: The option is exercisable to the extent of 91,667 shares on each of October 29, 2018 and October 29, 2019, and 91,666 shares on October 29, 2020. Read SEC document |
| March 25, 2019 Filed Mar 26, 2019 21:21 UTC |
Weinreb MarkDirector · CEO and Chairman of the Board
|
GrantStock Option · Derivative | 275,000 | Not disclosed Strike: $0.75 | Not disclosed |
DisclosureSEC source: 0001567619-19-007663 · doc1.xml · derivative · entry 19 Weinreb Mark · CIK 0001527212 · Director · CEO and Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 275,000 Underlying: Common Stock · 275,000 shares Expires 2027-06-23 F10 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F8 · derivative.exercise_date: The option is exercisable to the extent of 91,667 shares on each of June 23, 2017 and June 23, 2018, and 91,666 shares on June 23, 2019. Read SEC document |
| March 25, 2019 Filed Mar 26, 2019 21:21 UTC |
Weinreb MarkDirector · CEO and Chairman of the Board
|
Disposition to issuerStock Option · Derivative | 275,000 | Not disclosed Strike: $3.35 | Not disclosed |
DisclosureSEC source: 0001567619-19-007663 · doc1.xml · derivative · entry 18 Weinreb Mark · CIK 0001527212 · Director · CEO and Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 275,000 shares Expires 2027-06-23 F10 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F8 · derivative.exercise_date: The option is exercisable to the extent of 91,667 shares on each of June 23, 2017 and June 23, 2018, and 91,666 shares on June 23, 2019. Read SEC document |
| March 25, 2019 Filed Mar 26, 2019 21:21 UTC |
Weinreb MarkDirector · CEO and Chairman of the Board
|
GrantStock Option · Derivative | 275,000 | Not disclosed Strike: $0.75 | Not disclosed |
DisclosureSEC source: 0001567619-19-007663 · doc1.xml · derivative · entry 17 Weinreb Mark · CIK 0001527212 · Director · CEO and Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 275,000 Underlying: Common Stock · 275,000 shares Expires 2026-06-10 F10 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F7 · derivative.exercise_date: The option is exercisable to the extent of 91,667 shares on each of June 10, 2016 and June 10, 2017, and 91,666 shares on June 10, 2018. Read SEC document |
| March 25, 2019 Filed Mar 26, 2019 21:21 UTC |
Weinreb MarkDirector · CEO and Chairman of the Board
|
Disposition to issuerStock Option · Derivative | 275,000 | Not disclosed Strike: $3.73 | Not disclosed |
DisclosureSEC source: 0001567619-19-007663 · doc1.xml · derivative · entry 16 Weinreb Mark · CIK 0001527212 · Director · CEO and Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 275,000 shares Expires 2026-06-10 F10 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F7 · derivative.exercise_date: The option is exercisable to the extent of 91,667 shares on each of June 10, 2016 and June 10, 2017, and 91,666 shares on June 10, 2018. Read SEC document |
| March 25, 2019 Filed Mar 26, 2019 21:21 UTC |
Weinreb MarkDirector · CEO and Chairman of the Board
|
GrantStock Option · Derivative | 208,000 | Not disclosed Strike: $0.75 | Not disclosed |
DisclosureSEC source: 0001567619-19-007663 · doc1.xml · derivative · entry 15 Weinreb Mark · CIK 0001527212 · Director · CEO and Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 208,000 Underlying: Common Stock · 208,000 shares Expires 2025-09-04 F10 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F6 · derivative.exercise_date: The option is exercisable to the extent of 104,000 shares on December 22, 2015, 34,667 shares on each of September 4, 2016 and September 4, 2017, and 34,666 shares on September 4, 2018. Read SEC document |
| March 25, 2019 Filed Mar 26, 2019 21:21 UTC |
Weinreb MarkDirector · CEO and Chairman of the Board
|
Disposition to issuerStock Option · Derivative | 208,000 | Not disclosed Strike: $4.70 | Not disclosed |
DisclosureSEC source: 0001567619-19-007663 · doc1.xml · derivative · entry 14 Weinreb Mark · CIK 0001527212 · Director · CEO and Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 208,000 shares Expires 2025-09-04 F10 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F6 · derivative.exercise_date: The option is exercisable to the extent of 104,000 shares on December 22, 2015, 34,667 shares on each of September 4, 2016 and September 4, 2017, and 34,666 shares on September 4, 2018. Read SEC document |
| March 25, 2019 Filed Mar 26, 2019 21:21 UTC |
Weinreb MarkDirector · CEO and Chairman of the Board
|
GrantStock Option · Derivative | 150,000 | Not disclosed Strike: $0.75 | Not disclosed |
DisclosureSEC source: 0001567619-19-007663 · doc1.xml · derivative · entry 13 Weinreb Mark · CIK 0001527212 · Director · CEO and Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2024-10-23 F10 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F5 · derivative.exercise_date: The option is exercisable to the extent of 50,000 shares on each of October 23, 2015, October 23, 2016 and October 23, 2017. Read SEC document |
| March 25, 2019 Filed Mar 26, 2019 21:21 UTC |
Weinreb MarkDirector · CEO and Chairman of the Board
|
Disposition to issuerStock Option · Derivative | 150,000 | Not disclosed Strike: $4.70 | Not disclosed |
DisclosureSEC source: 0001567619-19-007663 · doc1.xml · derivative · entry 12 Weinreb Mark · CIK 0001527212 · Director · CEO and Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 150,000 shares Expires 2024-10-23 F10 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F5 · derivative.exercise_date: The option is exercisable to the extent of 50,000 shares on each of October 23, 2015, October 23, 2016 and October 23, 2017. Read SEC document |
| March 25, 2019 Filed Mar 26, 2019 21:21 UTC |
Weinreb MarkDirector · CEO and Chairman of the Board
|
GrantStock Option · Derivative | 50,000 | Not disclosed Strike: $0.75 | Not disclosed |
DisclosureSEC source: 0001567619-19-007663 · doc1.xml · derivative · entry 11 Weinreb Mark · CIK 0001527212 · Director · CEO and Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2024-02-18 F10 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F4 · derivative.exercise_date: The option is exercisable to the extent of 16,667 shares on each of February 18, 2014 and February 18, 2015 and 16,666 shares on February 18, 2016. Read SEC document |
| March 25, 2019 Filed Mar 26, 2019 21:21 UTC |
Weinreb MarkDirector · CEO and Chairman of the Board
|
Disposition to issuerStock Option · Derivative | 50,000 | Not disclosed Strike: $4.70 | Not disclosed |
DisclosureSEC source: 0001567619-19-007663 · doc1.xml · derivative · entry 10 Weinreb Mark · CIK 0001527212 · Director · CEO and Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 50,000 shares Expires 2024-02-18 F10 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F4 · derivative.exercise_date: The option is exercisable to the extent of 16,667 shares on each of February 18, 2014 and February 18, 2015 and 16,666 shares on February 18, 2016. Read SEC document |
| March 25, 2019 Filed Mar 26, 2019 21:21 UTC |
Weinreb MarkDirector · CEO and Chairman of the Board
|
GrantStock Option · Derivative | 12,500 | Not disclosed Strike: $0.75 | Not disclosed |
DisclosureSEC source: 0001567619-19-007663 · doc1.xml · derivative · entry 9 Weinreb Mark · CIK 0001527212 · Director · CEO and Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,500 Underlying: Common Stock · 12,500 shares Expires 2023-10-04 F10 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F3 · derivative.exercise_date: The option is exercisable to the extent of 6,250 shares on each of October 4, 2013 and October 4, 2014. Read SEC document |
| March 25, 2019 Filed Mar 26, 2019 21:21 UTC |
Weinreb MarkDirector · CEO and Chairman of the Board
|
Disposition to issuerStock Option · Derivative | 12,500 | Not disclosed Strike: $4.70 | Not disclosed |
DisclosureSEC source: 0001567619-19-007663 · doc1.xml · derivative · entry 8 Weinreb Mark · CIK 0001527212 · Director · CEO and Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,500 shares Expires 2023-10-04 F10 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F3 · derivative.exercise_date: The option is exercisable to the extent of 6,250 shares on each of October 4, 2013 and October 4, 2014. Read SEC document |
| March 25, 2019 Filed Mar 26, 2019 21:21 UTC |
Weinreb MarkDirector · CEO and Chairman of the Board
|
GrantStock Option · Derivative | 20,000 | Not disclosed Strike: $0.75 | Not disclosed |
DisclosureSEC source: 0001567619-19-007663 · doc1.xml · derivative · entry 7 Weinreb Mark · CIK 0001527212 · Director · CEO and Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2022-12-07 F10 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F2 · derivative.exercise_date: The option is exercisable to the extent of 10,000 shares on each of December 7, 2012 and December 7, 2013. Read SEC document |
| March 25, 2019 Filed Mar 26, 2019 21:21 UTC |
Weinreb MarkDirector · CEO and Chairman of the Board
|
Disposition to issuerStock Option · Derivative | 20,000 | Not disclosed Strike: $4.70 | Not disclosed |
DisclosureSEC source: 0001567619-19-007663 · doc1.xml · derivative · entry 6 Weinreb Mark · CIK 0001527212 · Director · CEO and Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,000 shares Expires 2022-12-07 F10 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F2 · derivative.exercise_date: The option is exercisable to the extent of 10,000 shares on each of December 7, 2012 and December 7, 2013. Read SEC document |
| March 25, 2019 Filed Mar 26, 2019 21:21 UTC |
Weinreb MarkDirector · CEO and Chairman of the Board
|
GrantStock Option · Derivative | 50,000 | Not disclosed Strike: $0.75 | Not disclosed |
DisclosureSEC source: 0001567619-19-007663 · doc1.xml · derivative · entry 5 Weinreb Mark · CIK 0001527212 · Director · CEO and Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2022-02-09 F10 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F1 · derivative.exercise_date: The option is exercisable to the extent of 16,667 shares on each of February 10, 2012 and February 10, 2013 and 16,666 shares on February 10, 2014. Read SEC document |
| March 25, 2019 Filed Mar 26, 2019 21:21 UTC |
Weinreb MarkDirector · CEO and Chairman of the Board
|
Disposition to issuerStock Option · Derivative | 50,000 | Not disclosed Strike: $4.70 | Not disclosed |
DisclosureSEC source: 0001567619-19-007663 · doc1.xml · derivative · entry 4 Weinreb Mark · CIK 0001527212 · Director · CEO and Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 50,000 shares Expires 2022-02-09 F10 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F1 · derivative.exercise_date: The option is exercisable to the extent of 16,667 shares on each of February 10, 2012 and February 10, 2013 and 16,666 shares on February 10, 2014. Read SEC document |
| March 25, 2019 Filed Mar 26, 2019 21:21 UTC |
Weinreb MarkDirector · CEO and Chairman of the Board
|
GrantStock Option · Derivative | 4,000 | Not disclosed Strike: $0.75 | Not disclosed |
DisclosureSEC source: 0001567619-19-007663 · doc1.xml · derivative · entry 3 Weinreb Mark · CIK 0001527212 · Director · CEO and Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,000 Underlying: Common Stock · 4,000 shares Expires 2020-12-14 F10 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. Read SEC document |
| March 25, 2019 Filed Mar 26, 2019 21:21 UTC |
Weinreb MarkDirector · CEO and Chairman of the Board
|
Disposition to issuerStock Option · Derivative | 4,000 | Not disclosed Strike: $4.70 | Not disclosed |
DisclosureSEC source: 0001567619-19-007663 · doc1.xml · derivative · entry 2 Weinreb Mark · CIK 0001527212 · Director · CEO and Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,000 shares Expires 2020-12-14 F10 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. Read SEC document |
| March 25, 2019 Filed Mar 26, 2019 21:19 UTC |
ALSTODT LANCEEVP and Chief Strategy Officer
|
GrantStock Option · Derivative | 500,000 | Not disclosed Strike: $0.75 | Not disclosed |
DisclosureSEC source: 0001567619-19-007660 · doc1.xml · derivative · entry 2 ALSTODT LANCE · CIK 0001756228 · EVP and Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500,000 Underlying: Common Stock · 500,000 shares Expires 2028-10-15 F2 · price: The reported transaction involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F1 · derivative.exercise_date: The option vests to the extent of 100,000 shares as of October 15, 2018, 150,000 shares upon the earlier of October 15, 2019 or the date on which the initial patient recruitment for the Company's Phase II lumbar clinical trial occurs, and 250,000 shares as of October 15, 2020. Read SEC document |
| March 25, 2019 Filed Mar 26, 2019 21:19 UTC |
ALSTODT LANCEEVP and Chief Strategy Officer
|
Disposition to issuerStock Option · Derivative | 500,000 | Not disclosed Strike: $1.42 | Not disclosed |
DisclosureSEC source: 0001567619-19-007660 · doc1.xml · derivative · entry 1 ALSTODT LANCE · CIK 0001756228 · EVP and Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 500,000 shares Expires 2028-10-15 F2 · price: The reported transaction involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F1 · derivative.exercise_date: The option vests to the extent of 100,000 shares as of October 15, 2018, 150,000 shares upon the earlier of October 15, 2019 or the date on which the initial patient recruitment for the Company's Phase II lumbar clinical trial occurs, and 250,000 shares as of October 15, 2020. Read SEC document |
| March 25, 2019 Filed Mar 26, 2019 21:15 UTC |
Clyde Mandy D.VP of Operations
|
GrantStock Option · Derivative | 50,000 | Not disclosed Strike: $0.75 | Not disclosed |
DisclosureSEC source: 0001567619-19-007658 · doc1.xml · derivative · entry 24 Clyde Mandy D. · CIK 0001527239 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2028-10-29 F12 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F11 · derivative.exercise_date: The option is exercisable to the extent of 16,667 shares on each of October 29, 2019 and October 29, 2020, and 16,666 shares on October 29, 2021. Read SEC document |
| March 25, 2019 Filed Mar 26, 2019 21:15 UTC |
Clyde Mandy D.VP of Operations
|
Disposition to issuerStock Option · Derivative | 50,000 | Not disclosed Strike: $1.23 | Not disclosed |
DisclosureSEC source: 0001567619-19-007658 · doc1.xml · derivative · entry 23 Clyde Mandy D. · CIK 0001527239 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 50,000 shares Expires 2028-10-29 F12 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F11 · derivative.exercise_date: The option is exercisable to the extent of 16,667 shares on each of October 29, 2019 and October 29, 2020, and 16,666 shares on October 29, 2021. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.